CovidChloroV1, Main, Corpus, bibRecord, 000B36

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations.

Identifieur interne : 000B36 ( Main/Corpus ); précédent : 000B35; suivant : 000B37

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations.

Auteurs : Partha Sarathi Biswas ; Devosri Sen

Source :

Therapeutic advances in drug safety [ 2042-0986 ] ; 2020.

RBID : pubmed:32983403
DOI: 10.1177/2042098620957141
PubMed: 32983403
PubMed Central: PMC7498962

Links to Exploration step

pubmed:32983403

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations.</title>
<author><name sortKey="Biswas, Partha Sarathi" sort="Biswas, Partha Sarathi" uniqKey="Biswas P" first="Partha Sarathi" last="Biswas">Partha Sarathi Biswas</name>
<affiliation><nlm:affiliation>Associate Professor, Department of Psychiatry, G.B. Pant Institute of P.G. Medical Education and Research (Maulana Azad Medical College), 1, Jawaharlal Nehru Marg, Raj Ghat, New Delhi 110002, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sen, Devosri" sort="Sen, Devosri" uniqKey="Sen D" first="Devosri" last="Sen">Devosri Sen</name>
<affiliation><nlm:affiliation>Clinical & Rehabilitation Psychologist, New Delhi, India.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32983403</idno>
<idno type="pmid">32983403</idno>
<idno type="doi">10.1177/2042098620957141</idno>
<idno type="pmc">PMC7498962</idno>
<idno type="wicri:Area/Main/Corpus">000B36</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000B36</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations.</title>
<author><name sortKey="Biswas, Partha Sarathi" sort="Biswas, Partha Sarathi" uniqKey="Biswas P" first="Partha Sarathi" last="Biswas">Partha Sarathi Biswas</name>
<affiliation><nlm:affiliation>Associate Professor, Department of Psychiatry, G.B. Pant Institute of P.G. Medical Education and Research (Maulana Azad Medical College), 1, Jawaharlal Nehru Marg, Raj Ghat, New Delhi 110002, India.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sen, Devosri" sort="Sen, Devosri" uniqKey="Sen D" first="Devosri" last="Sen">Devosri Sen</name>
<affiliation><nlm:affiliation>Clinical & Rehabilitation Psychologist, New Delhi, India.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Therapeutic advances in drug safety</title>
<idno type="ISSN">2042-0986</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32983403</PMID>
<DateRevised><Year>2020</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2042-0986</ISSN>
<JournalIssue CitedMedium="Print"><Volume>11</Volume>
<PubDate><Year>2020</Year>
</PubDate>
</JournalIssue>
<Title>Therapeutic advances in drug safety</Title>
<ISOAbbreviation>Ther Adv Drug Saf</ISOAbbreviation>
</Journal>
<ArticleTitle>Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations.</ArticleTitle>
<Pagination><MedlinePgn>2042098620957141</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1177/2042098620957141</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Biswas</LastName>
<ForeName>Partha Sarathi</ForeName>
<Initials>PS</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0003-4544-9234</Identifier>
<AffiliationInfo><Affiliation>Associate Professor, Department of Psychiatry, G.B. Pant Institute of P.G. Medical Education and Research (Maulana Azad Medical College), 1, Jawaharlal Nehru Marg, Raj Ghat, New Delhi 110002, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sen</LastName>
<ForeName>Devosri</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Clinical & Rehabilitation Psychologist, New Delhi, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>09</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Ther Adv Drug Saf</MedlineTA>
<NlmUniqueID>101549074</NlmUniqueID>
<ISSNLinking>2042-0986</ISSNLinking>
</MedlineJournalInfo>
<CoiStatement>Conflict of interest statement: The authors declare that there is no conflict of interest.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>5</Hour>
<Minute>42</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>9</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32983403</ArticleId>
<ArticleId IdType="doi">10.1177/2042098620957141</ArticleId>
<ArticleId IdType="pii">10.1177_2042098620957141</ArticleId>
<ArticleId IdType="pmc">PMC7498962</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Lancet Respir Med. 2020 Jun;8(6):539-541</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32304640</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antiviral Res. 2020 May;177:104762</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32147496</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 1996 Aug 31;313(7056):525-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8789977</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Oncogene. 2003 Jun 19;22(25):3927-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12813466</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Psychiatry. 2012 Dec 05;12:221</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23216941</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Malar J. 2016 Jun 22;15:332</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27335053</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Mal Infect. 2020 Jun;50(4):384</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32240719</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gen Hosp Psychiatry. 2014 Mar-Apr;36(2):181-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24290896</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Behav Immun. 2020 Jul;87:18-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32240762</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Apr;55(4):105932</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32145363</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mayo Clin Proc. 2020 Jun;95(6):1213-1221</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32359771</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 11;382(24):2327-2336</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32275812</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>CMAJ. 2014 Oct 21;186(15):1127-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25096666</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B36 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000B36 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32983403
   |texte=   Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32983403" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations.

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations.

Source :

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki